The global intramedullary (IM) nails market was valued at $1.2 billion in 2024 and is projected to grow at a CAGR of 3.2%, reaching approximately $1.5 billion by 2031.
The market is seeing steady growth driven by a rising preference for minimally invasive surgical techniques. IM nails enable smaller incisions, faster recovery, and reduced infection risks. Increased surgeon familiarity with these procedures is expected to support continued market expansion.
Market Data Included
- Unit Sales
- Average Selling Prices
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts to 2031
- Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Market Trends
A key driver of the IM nail market is the minimally invasive nature of the procedure, which results in reduced trauma and quicker rehabilitation. As healthcare providers continue to prioritize patient recovery times and surgical efficiency, demand for IM nails is expected to rise. Conversely, pricing pressures and high competition in certain regions may present short-term challenges to growth.
Market Share Insights (2024)
- 1 DePuy Synthes
- Market leader in 2024
- Offers the Advanced Nailing System and Expert Nail(R) line
- Strong presence across multiple anatomical segments
- Revenue growth expected through product innovation and expanded global reach
- 2 Stryker
- Second-largest market share
- Key product: T2(TM) Nail System
- Competitive pricing strategy has driven recent market share gains
- Well-positioned to expand due to focus on trauma solutions
- 3 Smith & Nephew
- Third-largest competitor
- Offers the TRIGEN(R) IM Nail for femur, humerus, and tibia
- Experienced modest market expansion, but growth expected to slow
- Faces challenges from stronger players in the space
Research Scope Summary
- Regions Covered
- North America: United States, Canada
- Latin America: Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela, and others
- Western Europe: France, Germany, U.K., Italy, Spain, Scandinavia, etc.
- Central & Eastern Europe: Russia, Turkey, Poland, Ukraine, Hungary, etc.
- Middle East: Saudi Arabia, UAE, Israel, Qatar, etc.
- Asia-Pacific: China, India, Japan, South Korea, Australia, etc.
- Africa: South Africa, Egypt, Nigeria, Kenya, Morocco, etc.
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2024
Quantitative Data
- Market Size & Forecasts
- Market Share
- Units Sold
- Average Selling Prices
- Growth Rates
Qualitative Data
- Growth Trends
- Market Limiters
- Competitive Analysis
- Company Profiles & Product Portfolios
- M&A Activity
- FDA Recalls
- Disruptive Technologies
Data Sources
- Primary Industry Interviews
- Government and Regulatory Databases
- Hospital Procurement Data
- Import/Export Records
- iData Research Internal Database